Studying how sugar metabolism affects immune skin cells in psoriasis
Part of Skin clinical trials.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for plaque psoriasis in the dermatology hospital unit at CHU Nice, and it is moderate to severe (PASI 10 or higher).
- A dermatologist has diagnosed you with plaque psoriasis (you may also have type 2 diabetes).
- If you are in the control group, you do not have psoriasis or other inflammatory skin conditions (with or without type 2 diabetes).
- You can agree and sign consent freely (the study does not include minors or people unable to consent).
- You are not pregnant or breastfeeding.
- You must be able to have a skin biopsy (you do not have bleeding problems, cannot take blood thinners, are not allergic to numbing medicine like lidocaine, and do not have a history of thick scar growth like keloids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
This study looks at the immune cells in skin samples from people with psoriasis who are being treated with an anti-IL-23 biologic. The goal is to understand why some areas of skin do not improve or why flares happen, which may help improve treatments.
This study looks at how inflammation-related genes behave in people with psoriasis. It may help researchers understand why psoriasis flares and how it could be better treated.
This study collects blood and other samples to see how the immune system changes “metabolism” (how your body uses energy) in people with immune-related conditions. Your samples may also be stored for future research and could help researchers better understand immune health.
This study looks at immune system differences in people with moderate-to-severe psoriasis. It aims to help guide more precise (targeted) treatment choices and may improve how well treatment works for you.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.